Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Hakl

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Vnitrni Lekarstvi|October 8, 2016
[Current treatment options for hereditary angioedema]Roman Hakl
Vnitrni Lekarstvi|March 17, 2023
Histamine intoleranceRoman Hakl, Jiří Litzman
Journal of Clinical Immunology|October 4, 2018
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During PregnancyRoman Hakl, Pavel Kuklínek, Irena Krčmová, et al.
Molecular Biology Reports|April 22, 2023
PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophagesLucie Ballonová, Petra Kulíšková, Peter Slanina, et al.
Mediators of Inflammation|June 26, 2019
Neutrophils Are Dysregulated in Patients with Hereditary Angioedema Types I and II in a Symptom-Free PeriodTereza Grymova, Marcela Vlkova, Premysl Soucek, et al.
Journal of Clinical Immunology|January 27, 2020
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon ActivationPavla Hujová, Přemysl Souček, Lucie Grodecká, et al.
International Archives of Allergy and Immunology|January 20, 2021
Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic PatientsMarta Sobotkova, Radana Zachova, Roman Hakl, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
Allergy and Asthma Proceedings|May 17, 2025
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimabPetra Staubach, Timothy J Craig, Tomoo Fukuda, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Vnitrni Lekarstvi|October 8, 2016
[Current treatment options for hereditary angioedema]Roman Hakl
Vnitrni Lekarstvi|March 17, 2023
Histamine intoleranceRoman Hakl, Jiří Litzman
Journal of Clinical Immunology|October 4, 2018
Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During PregnancyRoman Hakl, Pavel Kuklínek, Irena Krčmová, et al.
Molecular Biology Reports|April 22, 2023
PLAUR splicing pattern in hereditary angioedema patients' monocytes and macrophagesLucie Ballonová, Petra Kulíšková, Peter Slanina, et al.
Mediators of Inflammation|June 26, 2019
Neutrophils Are Dysregulated in Patients with Hereditary Angioedema Types I and II in a Symptom-Free PeriodTereza Grymova, Marcela Vlkova, Premysl Soucek, et al.
Journal of Clinical Immunology|January 27, 2020
Deep Intronic Mutation in SERPING1 Caused Hereditary Angioedema Through Pseudoexon ActivationPavla Hujová, Přemysl Souček, Lucie Grodecká, et al.
International Archives of Allergy and Immunology|January 20, 2021
Acquired Angioedema with C1 Inhibitor Deficiency: Occurrence, Clinical Features, and Management: A Nationwide Retrospective Study in the Czech Republic PatientsMarta Sobotkova, Radana Zachova, Roman Hakl, et al.
The World Allergy Organization Journal|May 17, 2021
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registryAnna Valerieva, Maria T Staevska, Vesna Grivcheva-Panovska, et al.
Allergy and Asthma Proceedings|May 17, 2025
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimabPetra Staubach, Timothy J Craig, Tomoo Fukuda, et al.
Lancet (London, England)|July 30, 2017
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trialMarc A Riedl, Vesna Grivcheva-Panovska, Dumitru Moldovan, et al.
Pageof 3